Browse
You are looking at 1 - 10 of 196 items for
Search for other papers by Cottrell T Tamessar in
Google Scholar
PubMed
Search for other papers by Amanda L. Anderson in
Google Scholar
PubMed
Search for other papers by Elizabeth G Bromfield in
Google Scholar
PubMed
Search for other papers by Natalie A Trigg in
Google Scholar
PubMed
Search for other papers by Shanmathi Parameswaran in
Google Scholar
PubMed
Search for other papers by Simone J Stanger in
Google Scholar
PubMed
Search for other papers by Judith Weidenhofer in
Google Scholar
PubMed
Search for other papers by Hui-Ming Zhang in
Google Scholar
PubMed
Search for other papers by Sarah A Robertson in
Google Scholar
PubMed
Search for other papers by David Sharkey in
Google Scholar
PubMed
Search for other papers by Brett Nixon in
Google Scholar
PubMed
Search for other papers by John E Schjenken in
Google Scholar
PubMed
Seminal fluid extracellular vesicles (SFEVs) have previously been shown to interact with spermatozoa and influence their fertilisation capacity. Here, we sought to extend these studies by exploring the functional consequences of SFEV interactions with human spermatozoa. SFEVs were isolated from seminal fluid of normozoospermic donors prior to assessing the kinetics of sperm-SFEV binding in vitro, as well as the effects of these interactions on sperm capacitation, acrosomal exocytosis and motility profile. Biotin-labelled SFEV proteins were transferred primarily to the flagellum of spermatozoa within minutes of co-incubation, although additional foci of SFEV biotinylated proteins also labelled the mid-piece and head domain. Functional analyses of high-quality spermatozoa collected following liquification revealed that SFEVs did not influence sperm motility during incubation at pH 5, yet SFEVs induced subtle increases in total and progressive motility in sperm incubated with SFEVs at pH 7. Additional investigation of sperm motility kinematic parameters revealed that SFEVs significantly decreased beat cross frequency and increased distance straight line, linearity, straightness, straight line velocity, and wobble. SFEVs did not influence sperm capacitation status, or the ability of sperm to undergo acrosomal exocytosis. Functional assessment of both high- and low-quality spermatozoa collected prior to liquification showed limited SFEV influence, with these vesicles inducing only subtle decreases in beat cross frequency in spermatozoa of both groups. These findings raise the prospect that, aside from subtle effects on sperm motility, the encapsulated SFEV cargo may be destined for physiological targets other than the male germline, notably the female reproductive tract.
Search for other papers by Shen Chuen Khaw in
Google Scholar
PubMed
Search for other papers by Sarah Martins da Silva in
Google Scholar
PubMed
Infertility is estimated to affect more than 50 million couples around the world, with male factor accounting for half of these cases, yet there is a notable absence of effective treatment options for men, other than in-vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI). This review considers unlicensed and empirical treatments used for male subfertility, including hormonal therapy, phosphodiesterase inhibitors, and antioxidants. Compounds generally demonstrate variable improvements in sperm function but benefits for fertility are less clear.
There is a pressing need for effective treatment options for subfertile men, however, our knowledge of sperm function is limited, restricting the identification of precise treatment targets. The traditional drug discovery pathway is also notorious for its extensive resource and time requirements, often extending over decades and demanding significant financial investment. Unfortunately, a substantial number of potential therapies fail before reaching the marketplace. Furthermore, reliance on mammalian models is not possible in the drug development process for male subfertility, due to significant variability between animals and man.
We review recent breakthroughs and highlight novel methods aimed at improving the effectiveness and efficiency of drug discovery for male subfertility. High-throughput screening, combinatorial chemistry, and the repurposing of established medications have great potential. These strategies offer the promise of accelerating the pace of drug development, curbing the extensive demand for resources, and, in the case of drug repurposing, diminish the demand for comprehensive pharmacokinetic and pharmacodynamic studies. As these innovative approaches are adopted, the feasibility of addressing male subfertility through scientific advancements appears to be increasingly attainable.
Search for other papers by Urmila Diwekar in
Google Scholar
PubMed
Search for other papers by Shyam Gupta in
Google Scholar
PubMed
Search for other papers by Anjali Gahlan in
Google Scholar
PubMed
Search for other papers by Sumitra Hota in
Google Scholar
PubMed
Search for other papers by Kshitiz Murdia in
Google Scholar
PubMed
Search for other papers by Nitiz Murdia in
Google Scholar
PubMed
Search for other papers by Vipin Chandra in
Google Scholar
PubMed
Search for other papers by Nihar Bhoi in
Google Scholar
PubMed
Search for other papers by Sanjay Joag in
Google Scholar
PubMed
RESEARCH QUESTION: This study aimed to evaluate the effectiveness of a clinical decision support tool, Opt-IVF, in achieving the following outcomes: reducing the total cumulative dosage of Gonadotropins (Gn) used during controlled ovarian stimulation cycles and reducing the repeated ultrasonogram (USG) monitoring for follicular growth monitoring without compromising the number of good quality blastocysts obtained.
DESIGN: The study design employed a Multi-center Randomized Trial. The study enrolled 115 women aged 25–45 years undergoing IVF. Among the participants, 55 were randomly assigned to the intervention group (Opt-IVF), and 60 were randomly assigned to the control group. The intervention involved using a clinical decision support tool, Opt-IVF, to guide Gonadotropin dosing and trigger dates for a personalized controlled ovarian stimulation cycle.
RESULTS: The participants in the intervention group required significantly lower cumulative gonadotropin dosage during their controlled ovarian stimulation cycles. The intervention group had higher numbers of oocytes retrieved and M2 oocytes retrieved than the control group. The number of good quality blastocysts, the good blastocyst rate, the ovarian sensitivity index (OSI), and the pregnancy rate in the intervention group were significantly higher than in the control group.
CONCLUSIONS: The utilization of the clinical decision support tool led to several positive outcomes, including eliminating the need for ultrasound exams after day 5, reducing the dosage of gonadotropin required, and yielding significantly higher numbers of high-quality blastocysts and higher pregnancy rates. Thus, Opt-IVF can successfully provide a personalized, optimized, and simplified approach to superovulation. Opt-IVF consistently outperformed the clinical teams in all outcomes.
Robinson Research Institute, The University of Adelaide, Adelaide, South Australia
Search for other papers by Anmol Saini in
Google Scholar
PubMed
Robinson Research Institute, The University of Adelaide, Adelaide, South Australia
Freemasons Centre for Male Health and Wellbeing, The University of Adelaide, Adelaide, South Australia
Genea Pty Ltd, Sydney, New South Wales, Australia
Search for other papers by Nicole O McPherson in
Google Scholar
PubMed
Robinson Research Institute, The University of Adelaide, Adelaide, South Australia
Search for other papers by Mark B Nottle in
Google Scholar
PubMed
The present study determined whether adding granulocyte–macrophage colony-stimulating factor (GM-CSF) during in vitro oocyte maturation (IVM) could improve oocyte developmental competence by examining embryo development and implantation and birth rates following embryo transfer in mice. In an initial dose-response experiment, we demonstrated that the addition of 2 and 10 ng/mL GM-CSF during IVM increased cumulus expansion (P < 0.05) but did not affect fertilisation rate compared with the control group. The addition of 10 ng/mL increased blastocyst rate (17.0%; P < 0.05) and tended to increase the number of good quality blastocysts present at 96 h of culture (+19.4%; P = 0.06) and increased blastocyst inner cell mass (+25.2%; P < 0.001), trophectoderm (+29.9%; P < 0.01), and total cell numbers (+28.6%; P < 0.05). GM-CSF also reduced the incidence of DNA damage in blastocysts in the 10 ng/mL group (−16.2%) compared with the control group. These improvements translated into increases in implantation rate (+21.0%; P < 0.05) and birth rate (+17.0%; P < 0.001) following the transfer of vitrified blastocysts. GM-CSF treatment did not alter any fetal and placental parameters. Together these results suggest that the addition of GM-CSF during IVM may improve livestock in vitro embryo production and human IVM.
Lay summary
The ability to collect immature eggs from the ovaries and mature these in the laboratory is an important technology for treating certain types of infertility in women as well as for preserving their fertility, for example prior to cancer treatment. This technique is called in vitro oocyte maturation or IVM and is also used in animal breeding. However, pregnancy and birth rates in humans and animals using this technique are lower than that which can be achieved using natural mating. We have shown that adding GM-CSF, a molecule found in the ovary, during IVM can increase the number and quality of embryos produced in mice. We have also found that when these embryos are transferred to surrogate mothers, implantation and birth rates are increased. These results suggest that the addition of GM-CSF during IVM may improve pregnancy and birth rates in humans as well as animals.
Search for other papers by Beril Yuksel in
Google Scholar
PubMed
Search for other papers by Gonul Ozer in
Google Scholar
PubMed
Search for other papers by Ipek Nur Balin Duzguner in
Google Scholar
PubMed
Search for other papers by Aysu Akca in
Google Scholar
PubMed
Search for other papers by Yesim Kumtepe in
Google Scholar
PubMed
Search for other papers by Hakan Yelke in
Google Scholar
PubMed
Search for other papers by Semra Kahraman in
Google Scholar
PubMed
Search for other papers by George Liperis in
Google Scholar
PubMed
Search for other papers by Munevver Serdarogullari in
Google Scholar
PubMed
First-trimester pregnancy losses are commonly attributed to chromosomal abnormalities. The causes of pregnancy loss following transfer of a euploid embryo are not fully elucidated. The aim of this study was to evaluate clinical and embryological parameters for pregnancy failure following the transfer of a single euploid embryo. Pregnancy outcomes of single euploid embryo transfers from a single centre between January 2017 and March 2020 were retrospectively evaluated. Several clinical and embryological parameters were evaluated in consideration to pregnancy outcomes; total pregnancy loss and live birth (LB). Endometrial preparation type, number of previous frozen embryo transfer cycles, history of recurrent pregnancy loss, higher body mass index, presence of endometriosis and/or adenomyosis and embryo quality were found to be significantly different between two groups. Morphokinetic parameter analysis of 523 euploid embryos using time-lapse imaging did not show any statistical differences between the two groups; however, a significantly higher rate of uneven blastomeres in the cleavage stage was observed in the total pregnancy loss group. Evaluation of clinical and embryological data can reveal possible factors associated with pregnancy loss that can facilitate improved patient consultation. Feasible interventions can potentially increase the chance of achieving an LB.
Lay Abstract
Like natural pregnancies, not all pregnancies following fertility treatment go to term. The most common reason for these losses is that these embryos lack the genetic constitution compatible with live birth. Combined with fertility treatment, genetic tests can evaluate the genetic ability of embryos to go to term. Monitoring the outcome of pregnancies resulting from such embryos can help us identify whether and which conditions specific to treatment can lead to pregnancy loss. The analysis identified four parameters associated with embryo loss: Embryo quality and division patterns, existence of previous treatment and treatment type.
Department of Obstetrics and Gynaecology, Monash University, Melbourne, Clayton, Victoria, Australia
Search for other papers by Qian Feng in
Google Scholar
PubMed
Search for other papers by Nina Shigesi in
Google Scholar
PubMed
Search for other papers by Jun Guan in
Google Scholar
PubMed
Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
Search for other papers by Nilufer Rahmioglu in
Google Scholar
PubMed
Search for other papers by Mona Bafadhel in
Google Scholar
PubMed
Search for other papers by Kevin Paddon in
Google Scholar
PubMed
Search for other papers by Carol Hubbard in
Google Scholar
PubMed
Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
Search for other papers by Krina T Zondervan in
Google Scholar
PubMed
Search for other papers by Christian M Becker in
Google Scholar
PubMed
Search for other papers by Karin Hellner in
Google Scholar
PubMed
Graphical abstract
Abstract
Immunological dysregulation plays a fundamental role in the inflammatory aspects of endometriosis. Circulating blood leukocytes, one of the most abundant immune cell populations in the human body, have been shown diagnostic significance in some diseases. Nevertheless, the association between peripheral blood leukocyte counts and endometriosis remains unexplored to date.
We analyzed two targeted study cohorts: a tertiary center cohort (Endometriosis at Oxford University (ENDOX) Study: 325 cases/177 controls) and a large-scale population study (UK Biobank (UKBB): 1537 cases/6331 controls). In both datasets, peripheral venous blood sample results were retrieved, and counts of leukocyte subpopulations, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils, were analyzed. Logistic regression models were used to investigate the association of leukocyte subtype alterations with endometriosis status, adjusting for confounding factors. We demonstrate that a higher blood basophil level is associated with increased odds of endometriosis. This association was first discovered in the ENDOX cohort (basophils >0.04 × 109/L: OR 1.65 (95% CI: 1.06–2.57), P trend = 0.025) and replicated in the UKBB dataset (basophils >0.04 × 109/L: OR 1.26 (95% CI: 1.09–1.45), P trend = 0.001). Notably, women with basophil counts in the upper tercile had significantly increased odds of having stage III/IV endometriosis (ENDOX study: OR = 2.30, 95% CI (1.25–4.22), P trend = 0.007; UKBB study (OR = 1.40, 95% CI (1.07–1.85), P trend = 0.015). None of the other leukocyte subtypes showed an association. Our findings suggest an association between inflammatory responses and the pathogenesis of endometriosis; future studies are warranted to investigate whether the association is causal.
Lay summary
Endometriosis is a long-term disease affecting approximately 10% of women during their fertile age. It happens when the tissue similar to the lining of the womb grows in other parts of the body, commonly causing pelvic pain and subfertility. Most diagnostic tests for endometriosis are neither accurate nor reliable, leading to a long wait before a correct diagnosis. Looking for changes in blood cell counts could guide doctors for further testing to confirm diagnosis. Our study shows that a higher number of basophils, a specialized type of white cells, commonly measured in a simple blood test, are positively linked with a higher likelihood of endometriosis. The link becomes stronger in severe endometriosis cases. Although we are showing a robust link, whether this can be used to find endometriosis sooner needs to be tested in future studies.
Search for other papers by Katja Hummitzsch in
Google Scholar
PubMed
Search for other papers by Jasmine E Kelly in
Google Scholar
PubMed
Search for other papers by Nicholas Hatzirodos in
Google Scholar
PubMed
Search for other papers by Wendy M Bonner in
Google Scholar
PubMed
Search for other papers by Feng Tang in
Google Scholar
PubMed
Search for other papers by Hugh H Harris in
Google Scholar
PubMed
Adelaide Health and Medical Sciences Building, The University of Adelaide, South Australia, Australia
Search for other papers by Raymond J Rodgers in
Google Scholar
PubMed
Graphical abstract
Abstract
Reactive oxygen species (ROS) are a by-product of the activity of cytochrome P450 steroidogenic enzymes. Antioxidant enzymes protect against ROS damage. To identify if any particular antioxidant enzyme is used to protect against ROS produced by granulosa cells as follicles enlarge and produce oestradiol, we measured in the bovine granulosa cells the expression of two steroidogenic enzymes (CYP11A1, CYP19A1), important for progesterone and oestradiol production. We also measured the expression of the members (FDXR, FDX1, POR) of their electron transport chains (ETC). We measured antioxidant enzymes (GPXs 1–8, CAT, SODs 1 and 2, PRDXs 1–6, GSR, TXN, TXNRDs 1–3). Since selenium is an active component of GPXs, the selenium-uptake receptors (LRPs 2 and 8) were measured. Only the selenium-dependent GPX1 showed the same increase in expression as the steroidogenic enzymes did with increasing follicle size. GPX4 and PRDX2/6 decreased with follicle size, whereas SOD1/2, CAT, GSR, and TXNRD3 were lowest at the intermediate sizes. The other antioxidant enzymes were unchanged or expressed at low levels. The expression of the selenium-uptake receptor LRP8 also increased significantly with follicle size. Correlation analysis revealed statistically significant and strongly positive correlations of the steroidogenic enzymes and their ETCs with both GPX1 and LRP8. These results demonstrate a relationship between the expression of genes involved in steroidogenesis and selenium-containing antioxidant defence mechanisms. They suggest that during the late stages of folliculogenesis, granulosa cells are dependent on sufficient expression of GPX1 and the selenium transporter LRP8 to counteract increasing ROS levels caused by the production of steroid hormones.
Lay summary
In the ovary, eggs are housed in follicles which contain the cells that produce oestrogen in the days leading up to ovulation of the egg. Oestrogen is produced by the action of enzymes. However, some of these enzymes also produce by-products called reactive oxygen species (ROS). These are harmful to eggs. Fortunately, cells have protective antioxidant enzymes that can neutralise ROS. This study was interested in which particular antioxidant enzyme(s) might be involved in neutralising the ROS in follicle cells. It was found that only one antioxidant enzyme, GPX1, appeared to be co-regulated with the enzymes that produce oestrogen and progesterone in the follicular cells. GPX1 contains the essential mineral selenium. In summary, this study has identified which antioxidant appears to be involved in neutralising ROS in the days leading to ovulation. It highlights the importance of selenium in the diet.
Faculty of Medicine and Life Sciences, Hasselt University, Agoralaan, Diepenbeek, Belgium
Search for other papers by Willem Ombelet in
Google Scholar
PubMed
Search for other papers by Federica Lopes in
Google Scholar
PubMed
Infertility affects millions worldwide, with significant medical, financial, and emotional challenges, particularly in low- and middle-income countries (LMICs). Cultural, religious, financial, and gender-related barriers hinder access to treatment, exacerbating social and economic consequences, especially for women. Despite its prevalence, infertility often remains overlooked due to competing health priorities. However, global initiatives recognise infertility as a reproductive health concern, advocating for universal access to high-quality fertility care. In LMICs, limited resources and infrastructure impede access to treatment, prompting people to turn to alternative, often ineffective, non-biomedical solutions. Addressing these challenges requires implementing affordable fertility care services tailored to local contexts, supported by political commitment and community engagement. Emerging technologies offer promising solutions, but comprehensive education and training programs are essential for their effective implementation. By integrating fertility care into broader health policies and fostering partnerships, we can ensure equitable access to infertility treatment and support reproductive health worldwide.
Department of Animal Science, University of Wyoming, Laramie, Wyoming, USA
Search for other papers by Landon K Eldridge in
Google Scholar
PubMed
Search for other papers by Dallas R Soffa in
Google Scholar
PubMed
Search for other papers by Kyle J Hickman-Brown in
Google Scholar
PubMed
Search for other papers by Brooke E McAnally in
Google Scholar
PubMed
Search for other papers by Molly S Smith in
Google Scholar
PubMed
Search for other papers by Jeffrey G Wiegert in
Google Scholar
PubMed
Search for other papers by Rebecca K Poole in
Google Scholar
PubMed
The pioneer microbiome is the initial colonization and establishment of microorganisms within the neonate. The objective of this project was to quantify maternal and environmental contributions to the piglet's pioneer microbiome. Sterile swabs were used to collect samples from the gilt’s rectum, the farrowing crate before and after gilts were moved in, the gilt’s birth canal during farrowing, and the piglet’s rectum on days 0 (prior to suckling), 3, and 10 post farrowing and at weaning (21.6 ± 1.0 days post farrowing). During farrowing, colostrum was collected from each gilt from a representative sample of teats into a single sterile collection cup. Bacterial DNA extraction and sequencing targeted the V4 hypervariable region of the 16S rRNA gene. The relative abundance of Lactobacillus in the piglet microbiome was lower on day 3 compared to day 0, day 10, and at weaning (P < 0.05). For alpha diversity, piglet samples exhibited distinct clustering for bacterial richness by day (P < 0.01). Multiple regression analyses indicated that the birth canal explained 51.6% of the variation observed in the piglet day 0 microbiome (P < 0.0001) and 6.5% of the variation in the piglet day 10 microbiome (P = 0.013). The day 10 microbiome explained 58.6% of the variation observed in the piglet microbiome at weaning (P < 0.0001). Bacterial communities of the farrowing crate and colostrum did not impact the piglet microbiome for any day (P > 0.10). The results indicate that the piglet pioneer microbiome is largely influenced by the microbiome of the birth canal.
Lay summary
The pioneer microbiome is the initial colonization of microbial organisms within an animal. For a newborn animal, these microbes can greatly affect their health and growth. It has been shown that the piglet pioneer microbiome is shaped by both maternal and environmental factors. However, it is unclear which source is the primary driver in shaping the microbiome in the newborn pig. The purpose of the study was to determine the piglet gut microbiome and to identify the maternal and environmental factors that contribute to the piglet microbiome from birth to weaning. The results showed that the majority of the piglet's pioneer gut microbiome at birth comes from the mother’s birth canal. This indicates a strong role of maternal factors in shaping the initial newborn’s microbiome. By weaning, the piglet microbiome becomes more stable, even with some disruptions in the microbiome early in life.
Search for other papers by Mary Ann Ottinger in
Google Scholar
PubMed
Search for other papers by Shailaja Mani in
Google Scholar
PubMed
Centre for Functional Biodiversity, School of Life Sciences, University of KwaZulu-Natal, Pietermaritzburg, South Africa
Search for other papers by Sonja Krüger in
Google Scholar
PubMed
Search for other papers by Brent Coverdale in
Google Scholar
PubMed
Search for other papers by Sandi Willows-Munro in
Google Scholar
PubMed
Search for other papers by Leigh Combrink in
Google Scholar
PubMed
Microbiomes have emerged as a key component essential for maintaining the health of an organism. Additionally, the roles of microbiomes are multifaceted, some unique to specific body areas and organs while others, particularly the gut microbiome, having broader effects on the entire organism. Comparative literature is emerging that compares microbiomes across mammals and birds. Domestic poultry have been the most extensively studied relative to their role in production agriculture. These data have provided a great deal of information about the effects of diet and nutritional requirements relative to the gut microbiome, productivity, and resilience to diseases. Conversely, limited research has been conducted on wild birds, despite them inhabiting a broad array of ecological niches and environments, providing a rich diversity in their adaptations to different habitats. Migratory birds and raptors are of particular interest. Migratory birds encounter a range of ecosystems and provide a link between allopatric populations. Raptors occupy high positions in the food chain, with potential exposure to biomagnification of environmental contaminants and pathogens. This review overviews our current understanding of the structure and function of avian microbiomes as related to avian health and reproduction in domestic and wild birds, highlighting knowledge gaps in need of further investigation for more effective conservation of rapidly declining avian populations.
Lay summary
Birds are among the most endangered organisms on the planet, vulnerable to many environmental challenges, including disease, loss of habitat, shortage of food resources, and climate-related change. They need to adapt to these challenges to survive and flourish. While the links between the gut microbiome, diet, resistance to infection, and behavior have been well studied in humans, laboratory animals, and domestic or captive birds, comparatively little is known about these associations in wildlife, where diet is expected to be more varied and seasonal. This is especially true for wild bird species. We review the information that is available on the microbiomes of both domestic and wild birds, highlighting knowledge gaps in our understanding of the health and reproduction of wild birds, toward furthering their conservation.
